Papagianni M, Avramidis N (2012). «Engineering the central pathways in Lactococcus lactis: functional expression of the phosphofructokinase (pfk) and alternative oxidase (aox1) genes from Aspergillus niger in Lactococcus lactis facilitates improved carbon conversion rates under oxidizing conditions». Enzyme and Microbial Technology51 (113): 125-30. PMID22759530. doi:10.1016/j.enzmictec.2012.04.007.
Phong WY, Lin W, Rao SP, Dick T, Alonso S, Pethe K (2013). «Characterization of Phosphofructokinase Activity in Mycobacterium tuberculosis Reveals That a Functional Glycolytic Carbon Flow Is Necessary to Limit the Accumulation of Toxic Metabolic Intermediates under Hypoxia». En Parish, Tanya, ed. PLOS ONE8 (2): 1198-206. PMID23409118. doi:10.1371/journal.pone.0056037.
Yi W, Clark PM, Mason DE, Keenan MC, Hill C, Goddard WA 3rd, Peters EC, Driggers EM, Hsieh-Wilson LC (2012). «Phosphofructokinase 1 glycosylation regulates cell growth and metabolism». Science337 (6097): 975-80. PMID22923583. doi:10.1126/science.1222278.
Banaszak K, Mechin I, Obmolova G, Oldham M, Chang SH, Ruiz T, Radermacher M, Kopperschläger G, Rypniewski W (2011). «The crystal structures of eukaryotic phosphofructokinases from baker's yeast and rabbit skeletal muscle». J Mol Biol.402 (7): 284-97. PMID21241708. doi:10.1016/j.jmb.2011.01.019.
Nakajima H, Raben N, Hamaguchi T, Yamasaki T (2002). «Phosphofructokinase deficiency; past, present and future». Curr. Mol. Med.2 (2): 197-212. PMID11949936. doi:10.2174/1566524024605734.
Bruser A, KirchbergerJ, Schoneberg T (2012). «AAltered allosteric regulation of muscle 6-phosphofructokinase causes Tarui disease». Biochem Biophys Res Commun427 (1): 133-7. PMID22995305. doi:10.1016/j.bbrc.2012.09.024.
nih.gov
ncbi.nlm.nih.gov
Papagianni M, Avramidis N (2012). «Engineering the central pathways in Lactococcus lactis: functional expression of the phosphofructokinase (pfk) and alternative oxidase (aox1) genes from Aspergillus niger in Lactococcus lactis facilitates improved carbon conversion rates under oxidizing conditions». Enzyme and Microbial Technology51 (113): 125-30. PMID22759530. doi:10.1016/j.enzmictec.2012.04.007.
Phong WY, Lin W, Rao SP, Dick T, Alonso S, Pethe K (2013). «Characterization of Phosphofructokinase Activity in Mycobacterium tuberculosis Reveals That a Functional Glycolytic Carbon Flow Is Necessary to Limit the Accumulation of Toxic Metabolic Intermediates under Hypoxia». En Parish, Tanya, ed. PLOS ONE8 (2): 1198-206. PMID23409118. doi:10.1371/journal.pone.0056037.
Yi W, Clark PM, Mason DE, Keenan MC, Hill C, Goddard WA 3rd, Peters EC, Driggers EM, Hsieh-Wilson LC (2012). «Phosphofructokinase 1 glycosylation regulates cell growth and metabolism». Science337 (6097): 975-80. PMID22923583. doi:10.1126/science.1222278.
Banaszak K, Mechin I, Obmolova G, Oldham M, Chang SH, Ruiz T, Radermacher M, Kopperschläger G, Rypniewski W (2011). «The crystal structures of eukaryotic phosphofructokinases from baker's yeast and rabbit skeletal muscle». J Mol Biol.402 (7): 284-97. PMID21241708. doi:10.1016/j.jmb.2011.01.019.
Nakajima H, Raben N, Hamaguchi T, Yamasaki T (2002). «Phosphofructokinase deficiency; past, present and future». Curr. Mol. Med.2 (2): 197-212. PMID11949936. doi:10.2174/1566524024605734.
Bruser A, KirchbergerJ, Schoneberg T (2012). «AAltered allosteric regulation of muscle 6-phosphofructokinase causes Tarui disease». Biochem Biophys Res Commun427 (1): 133-7. PMID22995305. doi:10.1016/j.bbrc.2012.09.024.